MSLE
Satellos Bioscience Inc. Common Stock
NASDAQ: MSLE · HEALTHCARE · BIOTECHNOLOGY
$7.27
-4.47% today
Updated 2026-04-29
Market cap
$149.15M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.70
Dividend yield
—
52W range
$5 – $13
Volume
0.1M
Satellos Bioscience Inc. Common Stock (MSLE) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-66.40%
ROA
-40.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2021 | $0.00 | $-12.16M | — | — | — |
| 2022 | $0.00 | $-8.34M | — | — | — |
| 2023 | $0.00 | $-11.98M | — | — | — |
| 2024 | $0.00 | $-19.58M | — | — | — |
| 2025 | $0.00 | $-24.87M | — | — | — |